"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about CISPLATIN
• Ask Community about CISPLATIN
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

CISPLATIN Safety Questions, CISPLATIN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CISPLATIN. Our extensive database of CISPLATIN adverse events and CISPLATIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CISPLATIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

CISPLATIN Safety Reports

Total CISPLATIN reports: 1173.
CISPLATIN FDA safety alerts: No.
Reported deaths: 296    Reported hospitalizations: 953.
Take CISPLATIN Side Effects Survey or Share Your CISPLATIN Story. Read More Here.

Showing 1-75 of 1173 Next >

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 05, 2007. Female patient, 58 years of age, weighting 130.1 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, tooth abscess. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, ALLOPURINOL, DEXAMETHASONE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 06, 2007. Female patient, weighting 103.0 lb, was diagnosed with endometrial cancer recurrent and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CISPLATIN dosage: 69.7 MG CDDP: 50MG/M2 50MG/M2 DAY 1. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 06, 2007. Male patient, 57 years of age, was diagnosed with gastric cancer, anaemia, hypokalaemia, diarrhoea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, febrile neutropenia, malignant neoplasm progression. CISPLATIN dosage: unknown. During the same period patient was treated with IRON SULPHATETHIAMIN COMPOUND, POTASSIUM SUPPLEMENT, LOPERAMIDE. Patient was hospitalized. Patient died on 11/21/2006.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Male patient, 60 years of age, was diagnosed with oesophageal adenocarcinoma, blood pressure, insomnia, neuropathy, diabetes mellitus and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, COUMADIN, NORVASC, AMBIEN, LASIX, NEURONTIN, INSULIN, GLYBURIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 07, 2007. Female patient, weighting 45.19 lb, was diagnosed with bone sarcoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anorexia, congestive cardiomyopathy, fatigue, hepatic function abnormal, hypotension, metabolic acidosis. CISPLATIN dosage: 384 MG. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Male patient, weighting 194.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CISPLATIN dosage: 124 MG. During the same period patient was treated with ETOPOSIDE. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 07, 2007. Female patient, 64 years of age, weighting 169.8 lb, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, dehydration, dysphagia, nausea, salivary gland disorder, vomiting. CISPLATIN dosage: unknown. During the same period patient was treated with COMPAZINE, DECADRON, HYDROCODONE, PAXIL, SENNA, ZOFRAN. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer, atrial fibrillation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, circulatory collapse, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, SINTROM MITIS, FUROSEMIDE, SELOKEEN, ENALAPRIL MALEATE, VITAMIN B, LANOXIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/26/2006.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 08, 2007. Female patient, weighting 146.4 lb, was diagnosed with cervix carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: electrolyte imbalance, fatigue, hypotension, muscle spasms, urinary tract infection. CISPLATIN dosage: 44 MG. During the same period patient was treated with TAXOL, ALBUTEROL, ATIVAN, EMEND, MACRODANTIN, MAGNESIUM, PHENERGAN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2007. Female patient, weighting 109.3 lb, was diagnosed with cervix carcinoma recurrent and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased. CISPLATIN dosage: 439.5 MG. During the same period patient was treated with TAXOL. Patient recovered.

Consumer or non-health professional from GERMANY reported CISPLATIN problem on Jan 30, 2007. Male patient was diagnosed with seminoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cardiomyopathy. CISPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, BLEOMYCIN. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2007. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer, atrial fibrillation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, circulatory collapse, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, SINTROM MITIS, FUROSEMIDE, SELOKEEN, ENALAPRIL MALEATE, VITAMIN B, LANOXIN, DEXAMETHASONE. Patient was hospitalized. Patient died on 10/26/2006.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 07, 2007. Male patient, 57 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: leukopenia, thrombocytopenia, tooth infection. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient died on 01/26/2007.

CISPLATIN problem was reported by a Physician from ARGENTINA on Feb 06, 2007. Male patient, 67 years of age, weighting 154.8 lb, was diagnosed with lung neoplasm malignant, prophylaxis, prophylaxis of nausea and vomiting and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood urea increased, depressed level of consciousness, dyspnoea, respiratory disorder. CISPLATIN dosage: 75 MG/M2, EVERY THREE WEEKS. During the same period patient was treated with PEMETREXED, FOLIC ACID, VITAMIN B, ONDANSETRON, TRAMADOL, ENALAPRIL MALEATE, RANITIDINE, DEXAMETHASONE. Patient died on 02/06/2005.

Pharmacist from UNITED STATES reported CISPLATIN problem on Feb 14, 2007. Male patient, 60 years of age, weighting 169.0 lb, was diagnosed with laryngeal cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: 189MG (100MG/M2) IVPB IN 500 ML NS; 1 CYCLE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Physician from JAPAN on Feb 01, 2007. Female patient, 53 years of age, was diagnosed with ovarian epithelial cancer, interstitial lung disease and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: colitis, interstitial lung disease, large intestine perforation, neoplasm progression, white blood cell count increased. CISPLATIN dosage: 85 MG ON DAY 1, UNK. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, IRINOTECAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 14, 2007. Female patient, weighting 168.7 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood magnesium decreased. CISPLATIN dosage: 80 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2007. Female patient, 33 years of age, was diagnosed with gastric cancer, mucosal inflammation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, stomatitis. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, MOUTHWASH. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 09, 2007. Female patient, 73 years of age, was diagnosed with prophylaxis, nausea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, blood calcium decreased, blood fibrinogen increased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, GRANISETRON, DEXAMETHASONE, OMEPRAZOLE, ZOFRAN, ZOLPIDEM TARTRATE, FORTASEC. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Male patient, 57 years of age, was diagnosed with gastric cancer, anaemia, hypokalaemia, diarrhoea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, febrile neutropenia, malignant neoplasm progression, multi-organ failure. CISPLATIN dosage: unknown. During the same period patient was treated with IRON SULPHATETHIAMIN COMPOUND, POTASSIUM SUPPLEMENT, LOPERAMIDE. Patient was hospitalized. Patient died on 11/21/2006.

Consumer or non-health professional from IRELAND reported CISPLATIN problem on Feb 13, 2007. Male patient, 60 years of age, was diagnosed with gastric cancer, cancer pain, diabetes mellitus, constipation, prophylaxis of nausea and vomiting, stomatitis and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cholangitis, malignant neoplasm progression, upper gastrointestinal haemorrhage. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, INFUMORPH, GLICLAZIDE, METFORMIN, DOMPERIDONE, ORAMORPH, DIFFLAM. Patient was hospitalized. Patient died on 02/27/2006.

CISPLATIN problem was reported by a Health Professional from ITALY on Feb 05, 2007. Male patient, 39 years of age, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: electrocardiogram st segment elevation, fatigue, hypotension, myocardial ischaemia, ventricular arrhythmia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 12, 2007. Male patient, 54 years of age, was diagnosed with tongue carcinoma stage iii and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: 100 MG/M2=183 MG FIRST CYCLE IV. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2007. Female patient, weighting 144.0 lb, was diagnosed with endometrial cancer recurrent, endometrial cancer stage iii, endometrial cancer stage iv and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, white blood cell count decreased. CISPLATIN dosage: 86 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 09, 2007. Male patient, 58 years of age, was diagnosed with gastric cancer, diabetes mellitus, prophylaxis against gastrointestinal ulcer, gastrointestinal pain, anxiety, abdominal pain and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, gastric haemorrhage, multi-organ failure, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with DIANBEN, ULCERAL, SPASMOCTYL, LEXATIN, XUMADOL. Patient was hospitalized. Patient died on 08/08/2006.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, weighting 260.5 lb, was diagnosed with neoplasm malignant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, renal failure acute. CISPLATIN dosage: 170 MG IV / 21 DAYS. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 12, 2007. Female patient, 63 years of age, was diagnosed with ovarian cancer metastatic and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: intestinal prolapse, post procedural complication. CISPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, DOCETAXEL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 13, 2007. Male patient, 62 years of age, weighting 156.5 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, dysphagia, infection, lymphopenia, neutrophil count, opportunistic infection, pain, stomatitis, white blood cell count decreased. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 21, 2007. Female patient, weighting 103.6 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CISPLATIN dosage: 68 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Female patient, weighting 207.5 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, nausea, vomiting. CISPLATIN dosage: 100 MG. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 21, 2007. Female patient, weighting 196.4 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pneumonia. CISPLATIN dosage: 97 MG. During the same period patient was treated with TAXOL. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 07, 2007. Male patient, 65 years of age, was diagnosed with gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, conjunctivitis. CISPLATIN dosage: CYCLE 1 (159 MG, 1 IN 28 D) (159 MG) INTRAVENOUS DRIP. During the same period patient was treated with FLUOROURACIL, AMPHOTERICIN B, DEXPANTHENOL, FLUCONAZOLE, NEOTRACIN, AZIDAMFENICOL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 16, 2007. Male patient, 42 years of age, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: pneumonitis. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE, POTASSIUM CHLORIDE, MAGNESIUM, FUROSEMIDE, APREPITANT, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Female patient, 60 years of age, was diagnosed with metastatic gastric cancer, vitamin supplementation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, VITAMIN B. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 16, 2007. Male patient, 63 years of age, weighting 176.4 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, ACENOCOUMAROL, CITALOPRAM, DIAZEPAM, HYDROCHLOROTHIAZIDE, NIFEDIPINE, PARACETAMOL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Female patient, weighting 154.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, chills, dehydration, dyspnoea, female genital tract fistula, haemorrhage, hydronephrosis, hypocalcaemia. CISPLATIN dosage: 50 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from IRELAND reported CISPLATIN problem on Feb 14, 2007. Male patient, 60 years of age, was diagnosed with gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: iliac artery thrombosis. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 02, 2007. Female patient, weighting 154.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, chills, dehydration, diarrhoea, dyspnoea, female genital tract fistula, haemorrhage, hydronephrosis. CISPLATIN dosage: 50 MG. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 23, 2007. Female patient, weighting 109.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count decreased. CISPLATIN dosage: 75 MG. During the same period patient was treated with TOPOTECAN, DIPHENHYDRAMINE, FENTANYL TRANSDERMAL SYSTEM, MARINOL, METOCLOPRAMIDE, MORPHINE, ONDANSETRON. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 23, 2007. Female patient, weighting 109.0 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, white blood cell count abnormal, white blood cell count decreased. CISPLATIN dosage: 75 MG. During the same period patient was treated with TOPOTECAN, DIPHENHYDRAMINE, FENTANYL, MARINOL, METOCLOPRAMIDE, MORPHINE, ONDANSETRON. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 16, 2007. Male patient, 69 years of age, was diagnosed with metastatic gastric cancer, hypertension, insomnia, prophylaxis, pain, mucosal inflammation and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: leukopenia, mucosal inflammation, neutropenia, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, COZAAR, ORFIDAL, OMEPRAZOLE, SEVREDOL, DIFLUCAN. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with lung neoplasm malignant, analgesic effect, prophylaxis, cough, vasodilation procedure and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, FOLIC ACID, TRAMADOL, ENALAPRIL MALEATE, RANITIDINE, CODEINE, CILOSTAZOL, VITAMIN B. Patient died on 02/06/2005.

Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on Feb 14, 2007. Male patient, child 6 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: eye pain, optic atrophy, visual acuity reduced. CISPLATIN dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2007. Female patient, weighting 207.5 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: constipation, hypokalaemia, hyponatraemia, nausea, renal failure acute, small intestinal obstruction, vomiting. CISPLATIN dosage: 100 MG. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 28, 2007. Female patient, weighting 156.3 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia, sinusitis. CISPLATIN dosage: 92 MG. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 51 years of age, was diagnosed with gastric cancer, anaemia, cancer pain and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bronchopneumonia, haemorrhage, metastases to ovary, metastases to peritoneum, multi-organ failure, septic shock, tumour perforation. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, FERRUM, BUPRENORPHINE. Patient was hospitalized. Patient died on 06/25/2006.

Consumer or non-health professional from IRELAND reported CISPLATIN problem on Feb 20, 2007. Male patient, 67 years of age, was diagnosed with gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Male patient, weighting 178.6 lb, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 15, 2007. Male patient, 67 years of age, weighting 154.3 lb, was diagnosed with lung neoplasm malignant, analgesic effect, prophylaxis, cough, vasodilation procedure and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dyspnoea, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with ALIMTA, FOLIC ACID, TRAMADOL, ENALAPRIL MALEATE, RANITIDINE, CODEINE, CILOSTAZOL, VITAMIN B. Patient died on 02/06/2005.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Male patient, 40 years of age, weighting 114.6 lb, was diagnosed with gastric cancer, deep vein thrombosis, abdominal pain upper and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, deep vein thrombosis, hyperthermia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, WARFARIN, ACETAMINOPHEN, OMEPRAZOLE, ONDANSETRON, MANNITOL, CHLORIDE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 20, 2007. Male patient, 64 years of age, weighting 260.1 lb, was diagnosed with neoplasm malignant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hyperkalaemia, renal failure, renal failure acute. CISPLATIN dosage: unknown. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 21, 2007. Male patient, 66 years of age, weighting 103.6 lb, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia. CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE, PANTOPRAZOLE, FORMOTEROL FUMARATE, FENTANYL, TIOTROPIUM BROMIDE, FENOTEROL HYDROBROMIDE, ACETYLCYSTEINE, DIHYDROCODEINE BITARTRATE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Feb 20, 2007. Male patient, weighting 178.6 lb, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration. CISPLATIN dosage: unknown. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from IRELAND on Feb 23, 2007. Male patient, 57 years of age, was diagnosed with metastatic gastric cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: pancreatitis acute. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, ONDANSETRON. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on Feb 26, 2007. Male patient, child 6 years of age, was diagnosed with primitive neuroectodermal tumour and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: optic atrophy. CISPLATIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, VINCRISTINE. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Female patient, weighting 230.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, enterocutaneous fistula, malaise, nausea, neutropenia, pyrexia, rhinorrhoea, urinary tract infection, wound complication. CISPLATIN dosage: 100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 22, 2007. Male patient, 71 years of age, was diagnosed with metastatic gastric cancer, myocardial infarction and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: peritonitis, thrombocytopenia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, ASPIRIN, DILTIAZEM. Patient was hospitalized. Patient died on 04/05/2006.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Male patient, 58 years of age, was diagnosed with gastric cancer, diabetes mellitus, prophylaxis against gastrointestinal ulcer, gastrointestinal pain, anxiety, abdominal pain and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, gastric haemorrhage, multi-organ failure, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with DIANBEN, ULCERAL, SPASMOCTYL, LEXATIN, XUMADOL. Patient was hospitalized. Patient died on 08/08/2006.

Consumer or non-health professional from UNITED KINGDOM reported CISPLATIN problem on Mar 01, 2007. Female patient, 53 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: stomatitis. CISPLATIN dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Feb 26, 2007. Male patient, 60 years of age, was diagnosed with oesophageal adenocarcinoma, diabetes mellitus, blood pressure, insomnia, neuropathy and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, METFORMIN, COUMADIN, NORVASC, AMBIEN, LASIX, NEURONTIN, INSULIN. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Mar 02, 2007. Female patient, weighting 173.1 lb, was diagnosed with tonsil cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, mucosal inflammation, pain. CISPLATIN dosage: 50 MG/M2 IV Q3WKS. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from IRELAND on Feb 23, 2007. Male patient, 69 years of age, was diagnosed with gastric cancer, gastrooesophageal reflux prophylaxis, depression and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: syncope. CISPLATIN dosage: unknown. During the same period patient was treated with OMEPRAZOLE, LEXAPRO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Mar 05, 2007. Male patient, 57 years of age, was diagnosed with gastric cancer, anaemia, hypokalaemia, diarrhoea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, febrile neutropenia, malignant neoplasm progression. CISPLATIN dosage: unknown. During the same period patient was treated with IRON SULPHATETHIAMIN COMPOUND, POTASSIUM SUPPLEMENT, LOPERAMIDE. Patient was hospitalized. Patient died on 11/21/2006.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Female patient, weighting 230.8 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, enterocutaneous fistula, malaise, nausea, neutropenia, open wound, pain, pyrexia, rhinorrhoea. CISPLATIN dosage: 100 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported CISPLATIN problem on Mar 06, 2007. Male patient, 46 years of age, was diagnosed with gastric cancer, antifungal prophylaxis, pain, gout, anxiety, mucosal inflammation, nausea and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, DIFLUCAN, ROXANOL, ALLOPURINOL, ATIVAN, MOUTHWASH, FENTANYL, COMPAZINE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from GERMANY on Mar 06, 2007. Male patient, 57 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: dehydration, haemoglobin decreased, hypokalaemia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from HUNGARY reported CISPLATIN problem on Mar 02, 2007. Female patient, 68 years of age, was diagnosed with metastatic gastric cancer, anorexia, hypertension, diabetes mellitus, dyspepsia and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, hyperglycaemia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, MEGACE, NORMODIPINE, BETALOC, GLIBENCLAMIDE, ISOSOURCE, FAMOTIDINE. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Female patient, 66 years of age, was diagnosed with tonsil cancer, laryngeal cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: creatinine renal clearance decreased, malignant neoplasm progression. CISPLATIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, BLEOMYCIN, VINCRISTINE SULPHATE. Patient died.

Health Professional from UNITED STATES reported CISPLATIN problem on Mar 02, 2007. Female patient, 73 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased. CISPLATIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, THIOGUANINE. Patient recovered.

CISPLATIN problem was reported by a Health Professional from UNITED STATES on Mar 07, 2007. Female patient, 61 years of age, was diagnosed with gastric cancer, pain, prophylaxis, insomnia, constipation, mouth ulceration and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: anaemia, haemorrhage, hypokalaemia, malignant neoplasm progression, neutropenia, renal failure. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, TRAMACET, NEXIUM, ZOLPIDEM, LAXETTE, DULCOLAX, MYCOSTATIN. Patient was hospitalized. Patient died.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Mar 06, 2007. Female patient, weighting 103.6 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia. CISPLATIN dosage: 68 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Female patient, weighting 101.4 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: neutropenia, pyrexia. CISPLATIN dosage: 68 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, TAXOL. Patient was hospitalized. Patient recovered.

Health Professional from IRELAND reported CISPLATIN problem on Feb 21, 2007. Male patient, 62 years of age, was diagnosed with squamous cell carcinoma and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: chills, fatigue, pyrexia. CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

CISPLATIN problem was reported by a Physician from JAPAN on Feb 23, 2007. Female patient, 53 years of age, was diagnosed with ovarian epithelial cancer, interstitial lung disease and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, large intestine perforation, neoplasm progression. CISPLATIN dosage: 85 MG ON DAY 1,. During the same period patient was treated with PREDNISOLONE, METHYLPREDNISOLONE, IRINOTECAN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Mar 07, 2007. Female patient, weighting 154.3 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, pulmonary embolism. CISPLATIN dosage: 70 MG. Patient was hospitalized. Patient recovered.

Showing 1-75 of 1173 Next >

Ask Our Patient Community about CISPLATIN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin)